Showing results (41-50 of 171) with videos related to
Sort By:
Pageof 18
Journal of the Royal Society of New Zealand|July 31, 2026
Detection of Antibiotic-Resistant Campylobacter on Retail Chicken in New Zealand: A Sentinel SurveyKathleen J Sircombe, Daniel Pletzer, Sarah HookInternational Journal of Pharmaceutics|May 7, 2022
Amino acids improve aerosolization and chemical stability of potential inhalable amorphous Spray-dried ceftazidime for Pseudomonas aeruginosa lung infectionBishal Raj Adhikari, Shubhra Sinha, Keith C Gordon, et al.Plos One|May 21, 2020
Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genesMojtaba Moosavian, Nasrin Emam, Daniel Pletzer, et al.Journal of Pharmaceutical and Biomedical Analysis|December 27, 2016
Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosisMohammad A M Momin, Sim J Thien, Woravimol Krittaphol, et al.Current Opinion in Microbiology|June 19, 2016
Anti-biofilm peptides as a new weapon in antimicrobial warfareDaniel Pletzer, Shannon R Coleman, Robert Ew HancockPharmaceutics|September 28, 2023
Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro CharacterizationBasanth Babu Eedara, Claire Fan, Shubhra Sinha, et al.Langmuir : the ACS Journal of Surfaces and Colloids|December 23, 2010
Determination of the polar and total surface energy distributions of particulates by inverse gas chromatographyShyamal C Das, Ian Larson, David A V Morton, et al.International Journal of Pharmaceutics|March 11, 2018
The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powdersBasanth Babu Eedara, Bhamini Rangnekar, Colin Doyle, et al.Drug Development and Industrial Pharmacy|April 25, 2019
Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosisMohammad A M Momin, Shubhra Sinha, Ian G Tucker, et al.International Journal of Pharmaceutics|June 27, 2025
Preparation and in vitro characterization of inhalable cannabidiol dry powder for treating chronic obstructive pulmonary diseaseKomal Komal, Shuli Chen, Lyall R Hanton, et al.Pageof 18